A new faster acting within 2.5 minutes mealtime version of insulin aspart Fiasp Novo Nordisk for the treatment of type 1 and type 2 diabetes in adults by the US Food and Drug Administration FDA . It also contains niacinamide to increase speed of the initial insulin absorption. Available as a prefilled delivery device and in a vial Fiasp is to be administered at the beginning of a meal or within 20 min after starting a meal.